170 related articles for article (PubMed ID: 33197269)
1. Systemic overexpression of interleukin-22 induces the negative immune-regulator SOCS3 and potently reduces experimental arthritis in mice.
Aarts J; Roeleveld DM; Helsen MM; Walgreen B; Vitters EL; Kolls J; van de Loo FA; van Lent PL; van der Kraan PM; Koenders MI
Rheumatology (Oxford); 2021 Apr; 60(4):1974-1983. PubMed ID: 33197269
[TBL] [Abstract][Full Text] [Related]
2. Protection against cartilage and bone destruction by systemic interleukin-4 treatment in established murine type II collagen-induced arthritis.
Joosten LA; Lubberts E; Helsen MM; Saxne T; Coenen-de Roo CJ; Heinegård D; van den Berg WB
Arthritis Res; 1999; 1(1):81-91. PubMed ID: 11056663
[TBL] [Abstract][Full Text] [Related]
3. Treatment with a neutralizing anti-murine interleukin-17 antibody after the onset of collagen-induced arthritis reduces joint inflammation, cartilage destruction, and bone erosion.
Lubberts E; Koenders MI; Oppers-Walgreen B; van den Bersselaar L; Coenen-de Roo CJ; Joosten LA; van den Berg WB
Arthritis Rheum; 2004 Feb; 50(2):650-9. PubMed ID: 14872510
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of interleukin-33 signaling attenuates the severity of experimental arthritis.
Palmer G; Talabot-Ayer D; Lamacchia C; Toy D; Seemayer CA; Viatte S; Finckh A; Smith DE; Gabay C
Arthritis Rheum; 2009 Mar; 60(3):738-49. PubMed ID: 19248109
[TBL] [Abstract][Full Text] [Related]
5. A crucial role for tumor necrosis factor receptor 1 in synovial lining cells and the reticuloendothelial system in mediating experimental arthritis.
Arntz OJ; Geurts J; Veenbergen S; Bennink MB; van den Brand BT; Abdollahi-Roodsaz S; van den Berg WB; van de Loo FA
Arthritis Res Ther; 2010; 12(2):R61. PubMed ID: 20370892
[TBL] [Abstract][Full Text] [Related]
6. Interleukin-22 reduces the severity of collagen-induced arthritis in association with increased levels of interleukin-10.
Sarkar S; Zhou X; Justa S; Bommireddy SR
Arthritis Rheum; 2013 Apr; 65(4):960-71. PubMed ID: 23334981
[TBL] [Abstract][Full Text] [Related]
7. Interleukin-21 promotes osteoclastogenesis in humans with rheumatoid arthritis and in mice with collagen-induced arthritis.
Kwok SK; Cho ML; Park MK; Oh HJ; Park JS; Her YM; Lee SY; Youn J; Ju JH; Park KS; Kim SI; Kim HY; Park SH
Arthritis Rheum; 2012 Mar; 64(3):740-51. PubMed ID: 21968544
[TBL] [Abstract][Full Text] [Related]
8. IL-38 overexpression induces anti-inflammatory effects in mice arthritis models and in human macrophages in vitro.
Boutet MA; Najm A; Bart G; Brion R; Touchais S; Trichet V; Layrolle P; Gabay C; Palmer G; Blanchard F; Le Goff B
Ann Rheum Dis; 2017 Jul; 76(7):1304-1312. PubMed ID: 28288964
[TBL] [Abstract][Full Text] [Related]
9. Therapeutic efficacy of Tyro3, Axl, and Mer tyrosine kinase agonists in collagen-induced arthritis.
van den Brand BT; Abdollahi-Roodsaz S; Vermeij EA; Bennink MB; Arntz OJ; Rothlin CV; van den Berg WB; van de Loo FA
Arthritis Rheum; 2013 Mar; 65(3):671-80. PubMed ID: 23203851
[TBL] [Abstract][Full Text] [Related]
10. Adenoviral delivery of IL-18 binding protein C ameliorates collagen-induced arthritis in mice.
Smeets RL; van de Loo FA; Arntz OJ; Bennink MB; Joosten LA; van den Berg WB
Gene Ther; 2003 Jun; 10(12):1004-11. PubMed ID: 12776157
[TBL] [Abstract][Full Text] [Related]
11. Complementary action of granulocyte macrophage colony-stimulating factor and interleukin-17A induces interleukin-23, receptor activator of nuclear factor-κB ligand, and matrix metalloproteinases and drives bone and cartilage pathology in experimental arthritis: rationale for combination therapy in rheumatoid arthritis.
van Nieuwenhuijze AE; van de Loo FA; Walgreen B; Bennink M; Helsen M; van den Bersselaar L; Wicks IP; van den Berg WB; Koenders MI
Arthritis Res Ther; 2015 Jun; 17(1):163. PubMed ID: 26081345
[TBL] [Abstract][Full Text] [Related]
12. Chimeric anti-IL-17 full-length monoclonal antibody is a novel potential candidate for the treatment of rheumatoid arthritis.
Bai F; Tian H; Niu Z; Liu M; Ren G; Yu Y; Sun T; Li S; Li D
Int J Mol Med; 2014 Mar; 33(3):711-21. PubMed ID: 24378614
[TBL] [Abstract][Full Text] [Related]
13. An opposing time-dependent immune-modulating effect of the sympathetic nervous system conferred by altering the cytokine profile in the local lymph nodes and spleen of mice with type II collagen-induced arthritis.
Härle P; Möbius D; Carr DJ; Schölmerich J; Straub RH
Arthritis Rheum; 2005 Apr; 52(4):1305-13. PubMed ID: 15818682
[TBL] [Abstract][Full Text] [Related]
14. Point mutation of tyrosine 759 of the IL-6 family cytokine receptor, gp130, augments collagen-induced arthritis in DBA/1J mice.
Tsuji F; Yoshimi M; Katsuta O; Takai M; Ishihara K; Aono H
BMC Musculoskelet Disord; 2009 Feb; 10():23. PubMed ID: 19228423
[TBL] [Abstract][Full Text] [Related]
15. Adenoviral vector-mediated overexpression of IL-4 in the knee joint of mice with collagen-induced arthritis prevents cartilage destruction.
Lubberts E; Joosten LA; van Den Bersselaar L; Helsen MM; Bakker AC; van Meurs JB; Graham FL; Richards CD; van Den Berg WB
J Immunol; 1999 Oct; 163(8):4546-56. PubMed ID: 10510398
[TBL] [Abstract][Full Text] [Related]
16. Effectiveness of the soluble form of the interleukin-1 receptor accessory protein as an inhibitor of interleukin-1 in collagen-induced arthritis.
Smeets RL; van de Loo FA; Joosten LA; Arntz OJ; Bennink MB; Loesberg WA; Dmitriev IP; Curiel DT; Martin MU; van den Berg WB
Arthritis Rheum; 2003 Oct; 48(10):2949-58. PubMed ID: 14558102
[TBL] [Abstract][Full Text] [Related]
17. Schistosoma mansoni infection reduces severity of collagen-induced arthritis via down-regulation of pro-inflammatory mediators.
Osada Y; Shimizu S; Kumagai T; Yamada S; Kanazawa T
Int J Parasitol; 2009 Mar; 39(4):457-64. PubMed ID: 18835272
[TBL] [Abstract][Full Text] [Related]
18. Splenic suppressor of cytokine signaling 3 transgene expression affects T cell responses and prevents development of collagen-induced arthritis.
Veenbergen S; Bennink MB; de Hooge AS; Arntz OJ; Smeets RL; van den Berg WB; van de Loo FA
Arthritis Rheum; 2008 Dec; 58(12):3742-52. PubMed ID: 19035473
[TBL] [Abstract][Full Text] [Related]
19. IL-1 alpha beta blockade prevents cartilage and bone destruction in murine type II collagen-induced arthritis, whereas TNF-alpha blockade only ameliorates joint inflammation.
Joosten LA; Helsen MM; Saxne T; van De Loo FA; Heinegard D; van Den Berg WB
J Immunol; 1999 Nov; 163(9):5049-55. PubMed ID: 10528210
[TBL] [Abstract][Full Text] [Related]
20. Anticytokine treatment of established type II collagen-induced arthritis in DBA/1 mice: a comparative study using anti-TNFalpha, anti-IL-1alpha/beta and IL-1Ra.
Joosten LA; Helsen MM; van de Loo FA; van den Berg WB
Arthritis Rheum; 2008 Feb; 58(2 Suppl):S110-22. PubMed ID: 18240201
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
